The Board of Directors of BrightGene Bio-Medical Technology Co., Ltd. has authorized a buyback plan on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.99 CNY | +0.91% | +20.21% | -11.46% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.46% | 1.79B | |
+34.40% | 664B | |
+29.29% | 567B | |
-7.27% | 354B | |
+19.18% | 330B | |
+4.71% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.67% | 148B |
- Stock Market
- Equities
- 688166 Stock
- News BrightGene Bio-Medical Technology Co., Ltd.
- BrightGene Bio-Medical Technology Co., Ltd. authorizes a Buyback Plan.